Literature DB >> 18705826

Six novel mutations of the ADAR1 gene in patients with dyschromatosis symmetrica hereditaria: histological observation and comparison of genotypes and clinical phenotypes.

Taisuke Kondo1, Tamio Suzuki, Yoshihiko Mitsuhashi, Shiro Ito, Michihiro Kono, Mayumi Komine, Hirotaka Akita, Yasushi Tomita.   

Abstract

Dyschromatosis symmetrica hereditaria (DSH), is a pigmentary genodermatosis of autosomal dominant inheritance. Since we clarified that the disease is caused by a mutation of the adenosine deaminase acting on the RNA 1 gene (ADAR1) in 2003, the molecular pathogenesis of a peculiar clinical feature of the disease has been expected to be clarified. We examined five familial cases and one sporadic case of Japanese families with DSH. The mutation analyses were done with single-strand conformation polymorphism/heteroduplex (SSCP/HD) analysis and direct sequencing of ADAR1. The DNA analysis of each patient revealed one missense mutation (p.F1091S), two nonsense mutations (p.C893X, p.S581X) and three frame-shift mutations (p.E498fsX517, p.F1091fsX1092, p.L855fsX856). Visual and electron microscopic findings showed abundant melanin pigment deposited all over the basal layer, and enlarged melanocytes with long dendrites located in the pigmented lesions with small or immature melanosomes scattered sparsely in the cytoplasm, but in the adjacent keratinocytes many small melanosomes were singly dispersed or aggregated. The hypopigmented areas showed little melanin deposition and reduced numbers of melanocytes in which much degenerative cytoplasmic vacuole formation could be observed by electron microscopy. Herein, we report six cases of DSH with six novel mutations. The variety of their clinical phenotypes even in the pedigree may suggest the presence of factors other than the ADAR1 gene influencing the extent of the clinical skin lesion. Microscopic findings suggest that the clinical appearance must have developed directly by melanocyte variations mainly induced by the ADAR1 gene mutations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18705826     DOI: 10.1111/j.1346-8138.2008.00493.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  13 in total

1.  Case Report: Aicardi-Goutières Syndrome Type 6 and Dyschromatosis Symmetrica Hereditaria With Congenital Heart Disease and Mitral Valve Calcification - Phenotypic Variants Caused by Adenosine Deaminase Acting on the RNA 1 Gene Homozygous Mutations.

Authors:  Lingjuan Liu; Lu Zhang; Peng Huang; Jie Xiong; Yangyang Xiao; Cheng Wang; Dingan Mao; Liqun Liu
Journal:  Front Pediatr       Date:  2022-06-27       Impact factor: 3.569

2.  Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature.

Authors:  Gillian I Rice; Paul R Kasher; Gabriella M A Forte; Niamh M Mannion; Sam M Greenwood; Marcin Szynkiewicz; Jonathan E Dickerson; Sanjeev S Bhaskar; Massimiliano Zampini; Tracy A Briggs; Emma M Jenkinson; Carlos A Bacino; Roberta Battini; Enrico Bertini; Paul A Brogan; Louise A Brueton; Marialuisa Carpanelli; Corinne De Laet; Pascale de Lonlay; Mireia del Toro; Isabelle Desguerre; Elisa Fazzi; Angels Garcia-Cazorla; Arvid Heiberg; Masakazu Kawaguchi; Ram Kumar; Jean-Pierre S-M Lin; Charles M Lourenco; Alison M Male; Wilson Marques; Cyril Mignot; Ivana Olivieri; Simona Orcesi; Prab Prabhakar; Magnhild Rasmussen; Robert A Robinson; Flore Rozenberg; Johanna L Schmidt; Katharina Steindl; Tiong Y Tan; William G van der Merwe; Adeline Vanderver; Grace Vassallo; Emma L Wakeling; Evangeline Wassmer; Elizabeth Whittaker; John H Livingston; Pierre Lebon; Tamio Suzuki; Paul J McLaughlin; Liam P Keegan; Mary A O'Connell; Simon C Lovell; Yanick J Crow
Journal:  Nat Genet       Date:  2012-09-23       Impact factor: 38.330

Review 3.  To protect and modify double-stranded RNA - the critical roles of ADARs in development, immunity and oncogenesis.

Authors:  Emily A Erdmann; Ananya Mahapatra; Priyanka Mukherjee; Boyoon Yang; Heather A Hundley
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-12-27       Impact factor: 8.250

4.  Five novel mutations in the ADAR1 gene associated with dyschromatosis symmetrica hereditaria.

Authors:  Qi Liu; Zhen Wang; Yuhong Wu; Lihua Cao; Qingzhu Tang; Xuesha Xing; Hongwei Ma; Shifa Zhang; Yang Luo
Journal:  BMC Med Genet       Date:  2014-06-20       Impact factor: 2.103

5.  Differential Diagnosis of Two Chinese Families with Dyschromatoses by Targeted Gene Sequencing.

Authors:  Jia-Wei Liu; Jun Sun; Sergio Vano-Galvan; Feng-Xia Liu; Xiu-Xiu Wei; Dong-Lai Ma
Journal:  Chin Med J (Engl)       Date:  2016-01-05       Impact factor: 2.628

Review 6.  Functions of the RNA Editing Enzyme ADAR1 and Their Relevance to Human Diseases.

Authors:  Chunzi Song; Masayuki Sakurai; Yusuke Shiromoto; Kazuko Nishikura
Journal:  Genes (Basel)       Date:  2016-12-17       Impact factor: 4.096

7.  Dyschromatosis symmetrica hereditaria with cutaneous lupus erythematosus and hyperthyroidism.

Authors:  Fahad Al-Saif; Ahmed Alhumidi; Rama Ayed Alhallaf
Journal:  Int Med Case Rep J       Date:  2017-05-02

8.  Analysis of genotype/phenotype correlations in Japanese patients with dyschromatosis symmetrica hereditaria.

Authors:  Tomoko Kobayashi; Michihiro Kono; Mutsumi Suganuma; Hirotaka Akita; Ayaka Takai; Kiyohiro Tsutsui; Yu Inasaka; Takuya Takeichi; Yoshinao Muro; Masashi Akiyama
Journal:  Nagoya J Med Sci       Date:  2018-05       Impact factor: 1.131

9.  Follicular occlusion triad associated with reticulate pigmentary disorder: is there a genetic linkage?

Authors:  Vijay Gandhi; Prashant Verma; Pravesh Yadav
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

10.  Reticulate dermatoses.

Authors:  Keshavmurthy A Adya; Arun C Inamadar; Aparna Palit
Journal:  Indian J Dermatol       Date:  2014-01       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.